Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Wednesday, November 14, 2018 · 468,233,318 Articles · 3+ Million Readers

Methionine Aminopeptidase 2 - Disease Assessment and Therapeutics Analysis Forecasts to 2024

PUNE, INDIA, April 3, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Methionine Aminopeptidase 2 - Pipeline Review, H1 2018”

Methionine Aminopeptidase 2

Overview

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Methionine aminopeptidase 2 is an enzyme that in humans is encoded by the METAP2 gene. Methionine aminopeptidase 2 is a member of the dimetallohydrolase family is a cytosolic metalloenzyme that catalyzes the hydrolytic removal of N-terminal methionine residues from nascent proteins.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3090690-methionine-aminopeptidase-2-initiation-factor-2-associated-67

 

Major Key Players:

Asieris Pharmaceuticals Co Ltd

Chong Kun Dang Pharmaceutical Corp

Merck KGaA

SynDevRx Inc

Takeda Pharmaceutical Co Ltd

Zafgen Inc

Methionine Aminopeptidase 2 Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Methionine Aminopeptidase 2    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Methionine Aminopeptidase 2   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 2, 5 and 2 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Methionine Aminopeptidase 2 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Methionine Aminopeptidase 2 - Competitive Analysis

Key players are making innovative developments in Methionine Aminopeptidase 2 industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Methionine Aminopeptidase 2.

The pipeline guide reviews pipeline therapeutics for Methionine Aminopeptidase 2 by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Methionine Aminopeptidase 2 therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Methionine Aminopeptidase 2 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Methionine Aminopeptidase 2.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3090690-methionine-aminopeptidase-2-initiation-factor-2-associated-67

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire